5 min listen
ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
FromASCO Education
ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
FromASCO Education
ratings:
Length:
8 minutes
Released:
Nov 8, 2017
Format:
Podcast episode
Description
Dr. Josh Lauring, Assistant Professor of Oncology at the Sidney Kimmel Cancer Center at John's Hopkins, presents the joint ASCO/AMP Guideline on Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in cancer, published in the Journal of Molecular Pathology in January 2017.
Released:
Nov 8, 2017
Format:
Podcast episode
Titles in the series (100)
Recently Approved Drugs: Pembrolizumab for cHL: Recently Approved Drugs: Pembrolizumab for cHL by ASCO Education